Biotage

Overview

Biotage, founded in 1969 and headquartered in Sweden, operates within the Business Services sector, specifically focusing on research and development. The company employs between 501 and 1,000 individuals and reported a revenue of approximately $171 million. Biotage specializes in innovative solutions for drug discovery, particularly in peptide purification and chromatography. Their document corpus includes a case study highlighting the use of their PurePep® EasyClean (PEC) technology, which allows for high-throughput purification of peptides in a 96-well plate format. This method addresses challenges in drug discovery by facilitating the purification of multiple peptides simultaneously, thereby improving the reliability of assay results and reducing the risks associated with using low-purity crude peptides. Additionally, Biotage has published a white paper on successful flash chromatography, indicating their expertise in chromatographic techniques. The company's focus on enhancing the efficiency and accuracy of peptide synthesis and purification processes underscores its commitment to advancing drug discovery methodologies.

Industry